4

PRIMARY DOCUMENT

Company: NYMOX PHARMACEUTICAL CORP
Filed: June 6, 2019
Period of Report: June 5, 2019
Accession Number: 0001651844-19-000007

View Document ↗ View on SEC.gov ↗